Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?
about
Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa.Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study.Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: a prospective study.Timing of initiation of antiretroviral drugs during tuberculosis therapy.Association of first-line and second-line antiretroviral therapy adherence.Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage studyEvaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapyRemote sensing of HIV care programmes using centrally collected laboratory results: can we monitor ART programme effectiveness?Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions.Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.Lessons Learned From a Paying Antiretroviral Therapy Service in the Public Health Sector at Kamuzu Central Hospital, Malawi
P2860
Q33533887-7EACDCFB-95C9-492D-9623-8FC0C5709A9EQ33619740-89534886-F122-42F3-9F25-2BDE8C60B21AQ33894714-32907486-E4CB-4A87-8491-3C4F4919A69CQ34288562-AAD6BA38-9859-4343-B8FB-7FE2C9D685D7Q34686754-874A27D2-1B57-459E-BF58-72ABFAD3837BQ34775439-AE785159-3CED-4040-83CD-7EB8AB2ED039Q34790184-76AADD5F-A782-4FEF-A1E8-2BAB889C6597Q34801978-B034AF26-5BD5-4A82-AEBB-A983FD21E004Q35606796-CACA7052-0244-4134-B05E-6F265C9E9B40Q37149013-2E97F0F6-B753-4857-8640-B41EE234330BQ37275865-C109E825-1B42-4B1C-83F5-66BE8FEF7E8FQ39747436-2F82FB87-AD9C-41C8-B087-3282DBFC7731Q47547617-12C35700-0648-466E-9F32-EBE6A8933534Q58389068-6FD19011-EDE3-4202-96A2-A9BBEEBFE99C
P2860
Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Efficacy of antiretroviral the ...... those in the developed world?
@en
Efficacy of antiretroviral the ...... those in the developed world?
@nl
type
label
Efficacy of antiretroviral the ...... those in the developed world?
@en
Efficacy of antiretroviral the ...... those in the developed world?
@nl
prefLabel
Efficacy of antiretroviral the ...... those in the developed world?
@en
Efficacy of antiretroviral the ...... those in the developed world?
@nl
P50
P356
P1476
Efficacy of antiretroviral the ...... those in the developed world?
@en
P304
1683-4; author reply 1684
P356
10.1086/498030
P407
P577
2005-12-01T00:00:00Z